Literature DB >> 10845020

Vitrectomy for vitreous opacification in Fuchs' heterochromic uveitis.

F M Waters1, K Goodall, N P Jones, D McLeod.   

Abstract

PURPOSE: To assess the role of pars plana vitrectomy (PPV) for symptomatic vitreous opacification in a series of patients with Fuchs' heterochromic uveitis (FHU).
METHODS: A retrospective review was undertaken of 13 patients with FHU who underwent vitrectomy for vitreous opacification between April 1989 and December 1998.
RESULTS: An improvement in visual symptoms was recorded in all patients, 9 of 13 (69%) demonstrating at least a 2 line increase in Snellen visual acuity. All but one patient attained 6/9 or better visual acuity post-operatively. Surgery was uneventful and did not appear to exacerbate any existing intraocular inflammation.
CONCLUSION: From this series we conclude that PPV has an important role in the management of patients with FHU who present with symptomatic vitreous opacification.

Entities:  

Mesh:

Year:  2000        PMID: 10845020     DOI: 10.1038/eye.2000.57

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?

Authors:  Bogomil Voykov; Christoph Deuter; Manfred Zierhut; Martin Alexander Leitritz; Emmanuella Guenova; Emmanuella Guenova-Hötzenecker; Deshka Doycheva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

2.  Evaluation of radial peripapillary capillary density in patients with Fuchs uveitis syndrome.

Authors:  Yasin Sakir Goker; Pinar Cakar Ozdal; Yasemin Ozdamar Erol; Hasan Kızıltoprak; Mustafa Salih Karatepe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

Review 3.  [Fuchs uveitis syndrome--heterochromia is no "conditio sine qua non"].

Authors:  M D Becker; M Zierhut
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

4.  Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs Heterochromic Iridocyclitis.

Authors:  Kaori Suzuki; Yukihiko Suzuki; Mitsuo Matsumoto; Mitsuru Nakazawa
Journal:  Case Rep Ophthalmol       Date:  2010-05-12

Review 5.  [Therapeutic vitrectomy in uveitis: current status and recommendations].

Authors:  M D Becker; N Harsch; M Zierhut; J L Davis; F G Holz
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

6.  Atypical Bilateral Fuchs Uveitis: Diagnostic Challenges.

Authors:  Cristóbal Couto; Erika Hurtado; Dana Faingold; Carmen Demetrio; Ariel Schlaen; Marcelo Zas; Jorge Zarate; Silvia Rosetti; Andrea Paes de Lima; Juan Oscar Croxatto; Pablo Chiaradía; Miguel N Burnier
Journal:  Case Rep Ophthalmol       Date:  2015-09-02

7.  Monoclonal immunoglobulin heavy chain gene rearrangement in Fuchs' uveitis.

Authors:  Hisae Nakahara; Toshikatsu Kaburaki; Rie Tanaka; Junko Matsuda; Mitsuko Takamoto; Kazuyoshi Ohtomo; Kimiko Okinaga; Keiko Komae; Jiro Numaga; Yujiro Fujino; Makoto Aihara
Journal:  BMC Ophthalmol       Date:  2018-03-09       Impact factor: 2.209

8.  Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan.

Authors:  Yu Yoneda; Yoshihiko Usui; Rie Tanaka; Keitaro Hase; Kenichi Namba; Koju Kamoi; Hiroshi Takase; Masaki Takeuchi; Wataru Matsumiya; Sentaro Kusuhara; Atsunobu Takeda; Nobuyo Yawata; Ryoji Yanai; Tomona Hiyama; Yosuke Harada; Noriyasu Hashida; Kazuichi Maruyama; Kei Nakai; Ryo Taguchi; Toshikatsu Kaburaki; Nobuhisa Mizuki; Hiroshi Goto; Yujiro Fujino; Masaru Takeuchi
Journal:  Front Med (Lausanne)       Date:  2022-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.